SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

IBO

Impact BioMedical Inc.
NYSE AmericanHealth Care

Latest close: 2.68 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 24, 2026Reported sale · Form 4DSS, INC. · $1.1KOpen the filing ↗
  3. Sep 23, 2026Reported sale · Form 4DSS, INC. · $187.7Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1344 flagged findings
Reported transactions (Form 4)3since Sep 22, 2026
Corporate events (8-K)1since Mar 4, 2026

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-09-15listing compliance noticefreshOpen filing ↗
    “…stock at a ratio within a range of 1-for-12.48 to 1-for-50, with the exact ratio to be determined at the discretion of the…”
  • 2026-09-15reverse splitfreshOpen filing ↗
    “…growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any…”
    +1 more passage from the same document
    • “…Act. ☐ Item 7.01 Regulation FD Disclosure On September 14, 2026, the Company released a press release relating to its proposed…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:12.62 on Sep 23, 2026) · 1:13 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 134)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 268-K ↗Current report · Bylaws or fiscal year change
  • Sep 24, 26Form 4 ↗Insider transaction
  • Sep 17, 26Form 425 ↗Merger, acquisition or tender offer
  • Sep 17, 268-K ↗Current report · Communication to the market
  • Sep 15, 26Form 425 ↗Merger, acquisition or tender offer
  • Sep 15, 268-K ↗Current report · Communication to the market
  • Aug 7, 2610-Q ↗Quarterly report
  • May 12, 2610-Q ↗Quarterly report
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Mar 11, 2610-K ↗Annual report
  • Mar 4, 268-K ↗Current report · Entered a material agreement
  • Jan 6, 26Form 4 ↗Insider transaction
  • Dec 30, 25DEF 14C ↗Shareholder meeting and votes
  • Dec 11, 25PRE 14C ↗Shareholder meeting and votes
  • Nov 7, 2510-Q ↗Quarterly report
  • Nov 6, 258-K ↗Current report · Shareholder vote results
  • Oct 27, 258-K ↗Current report · Other events
  • Sep 22, 25DEF 14A ↗Shareholder meeting and votes
  • Sep 9, 25DEF 14C ↗Shareholder meeting and votes
  • Aug 25, 25PRE 14C ↗Shareholder meeting and votes
  • Aug 14, 2510-Q ↗Quarterly report
  • Aug 5, 25DEF 14C ↗Shareholder meeting and votes
  • Jul 28, 258-K ↗Current report · Significant agreement signed
  • Jul 16, 25PRE 14C ↗Shareholder meeting and votes

134 filings on record, the oldest from Feb 12, 21.

Listing the 25 most recent filings of the 134 on record.

8-Ks, explained

Structure1
  • Mar 4, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Heng Fai Ambrose Chan2.9%Apr 2, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 24, 26Sell$1KDSS, INC.↗
  • Sep 23, 26Sell$188DSS, INC.↗
  • Sep 22, 26Sell$398DSS, INC.↗

The full record holds 3 transactions and goes back to Sep 22, 26.

Its sector and its market

Impact BioMedical Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Impact BioMedical Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Impact BioMedical Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
134 documents on file, from Feb 12, 2021 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.